Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

IKAST FYSIOTERAPI II ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.8% 3.5% 3.2% 2.6% 3.0% 3.4% 19.3% 18.9%   Credit score (0-100)   61 54 56 60 57 53 7 7   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   671 536 293 602 683 255 255 255   Gross profit   660 524 281 590 671 243 0.0 0.0   EBITDA   660 524 281 590 671 243 0.0 0.0   EBIT   660 524 281 590 671 243 0.0 0.0   Pre-tax profit (PTP)   659.6 524.2 280.9 594.8 675.2 262.8 0.0 0.0   Net earnings   513.5 408.8 219.0 463.9 526.7 205.0 0.0 0.0   Pre-tax profit without non-rec. items   660 524 281 595 675 263 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   564 972 1,191 1,155 932 637 86.9 86.9   Interest-bearing liabilities   817 43.9 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,568 1,117 1,290 1,315 1,101 697 86.9 86.9   Net Debt   817 43.8 -101 -51.0 -2.7 -0.1 -86.9 -86.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   671 536 293 602 683 255 255 255   Net sales growth   92.8% -20.0% -45.4% 105.6% 13.4% -62.6% 0.0% 0.0%   Gross profit   660 524 281 590 671 243 0.0 0.0   Gross profit growth   96.3% -20.5% -46.4% 110.1% 13.6% -63.8% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,568 1,117 1,290 1,315 1,101 697 87 87   Balance sheet change%   5.3% -28.7% 15.5% 1.9% -16.3% -36.7% -87.5% 0.0%   Added value   659.7 524.3 281.0 590.4 670.7 242.7 0.0 0.0   Added value %   98.4% 97.7% 95.9% 98.0% 98.2% 95.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   1.0 -1.0 -2.0 1.0 2.0 -1.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   98.4% 97.7% 95.9% 98.0% 98.2% 95.0% 0.0% 0.0%   EBIT %   98.4% 97.7% 95.9% 98.0% 98.2% 95.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   76.6% 76.2% 74.7% 77.0% 77.1% 80.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   76.6% 76.2% 74.7% 77.0% 77.1% 80.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   98.4% 97.7% 95.8% 98.7% 98.8% 102.9% 0.0% 0.0%   ROA %   43.2% 39.0% 23.3% 45.7% 56.0% 29.2% 0.0% 0.0%   ROI %   47.5% 43.2% 24.9% 50.0% 64.5% 32.7% 0.0% 0.0%   ROE %   117.6% 53.2% 20.2% 39.5% 50.5% 26.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   35.9% 87.0% 92.3% 87.9% 84.6% 91.4% 100.0% 100.0%   Relative indebtedness %   149.8% 21.2% 26.2% 24.7% 24.8% 8.4% 0.0% 0.0%   Relative net indebtedness %   149.8% 21.2% -8.2% 16.3% 24.4% 8.4% -34.0% -34.0%   Net int. bear. debt to EBITDA, %   123.9% 8.4% -35.9% -8.6% -0.4% -0.0% 0.0% 0.0%   Gearing %   145.0% 4.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.5% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 6.9 3.9 3.2 20.0 0.0 0.0   Current Ratio   0.0 0.0 6.9 3.9 3.2 20.0 0.0 0.0   Cash and cash equivalent   0.0 0.1 100.9 51.0 2.7 0.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 182.9 178.9 0.0 0.0   Current assets / Net sales %   6.4% 0.0% 180.8% 96.8% 78.5% 167.6% 34.0% 34.0%   Net working capital   -961.1 -113.9 453.0 434.1 367.1 406.7 0.0 0.0   Net working capital %   -143.3% -21.2% 154.6% 72.1% 53.7% 159.2% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   671 536 293 602 683 255 0 0   Added value / employee   660 524 281 590 671 243 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   660 524 281 590 671 243 0 0   EBIT / employee   660 524 281 590 671 243 0 0   Net earnings / employee   514 409 219 464 527 205 0 0